Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Germany biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.
The German biotechnology market had total revenue of $4,465.2 million in 2010, representing a compound annual growth rate (CAGR) of 1% between 2006 and 2010.
Medical/Healthcare sales proved the most lucrative for the German biotechnology market in 2010, with total revenues of $3,138.1 million, equivalent to 70.3% of the market's overall value.
The performance of the market is forecast to accelerate, with an anticipated CAGR of 7% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $6,260.1 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Germany economy

Key Questions Answered

What was the size of the Germany biotechnology market by value in 2010?

What will be the size of the Germany biotechnology market in 2015?

What factors are affecting the strength of competition in the Germany biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Germany's biotechnology market?

EXECUTIVE SUMMARY
MARKET OVERVIEW
- Market definition
- Research highlights
- Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
FIVE FORCES ANALYSIS
- Summary
- Buyer power
- Supplier power
- New entrants
- Substitutes
- Rivalry
LEADING COMPANIES
- Boehringer Ingelheim
- MediGene AG
- Merck KGaA
- Morphosys
MARKET FORECASTS
- Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
- Methodology
- Industry associations
- Related Datamonitor research
- Disclaimer
ABOUT DATAMONITOR
- Premium Reports
- Summary Reports
- Datamonitor consulting
LIST OF TABLES
- Table 1: Germany biotechnology market value: $ million, 2006-10
- Table 2: Germany biotechnology market segmentation I:% share, by value, 2010
- Table 3: Germany biotechnology market segmentation II: % share, by value, 2010
- Table 4: Boehringer Ingelheim : key facts
- Table 5: Boehringer Ingelheim : key financials ($)
- Table 6: Boehringer Ingelheim : key financials (€)
- Table 7: Boehringer Ingelheim : key financial ratios
- Table 8: MediGene AG: key facts
- Table 9: MediGene AG: key financials ($)
- Table 10: MediGene AG: key financials (€)
- Table 11: MediGene AG: key financial ratios
- Table 12: Merck KGaA: key facts
- Table 13: Merck KGaA: key financials ($)
- Table 14: Merck KGaA: key financials (€)
- Table 15: Merck KGaA: key financial ratios
- Table 16: Morphosys: key facts
- Table 17: Morphosys: key financials ($)
- Table 18: Morphosys: key financials (€)
- Table 19: Morphosys: key financial ratios
- Table 20: Germany biotechnology market value forecast: $ million, 2010-15
- Table 21: Germany size of population (million), 2006-10
- Table 22: Germany gdp (constant 2000 prices, $ billion), 2006-10
- Table 23: Germany gdp (current prices, $ billion), 2006-10
- Table 24: Germany inflation, 2006-10
- Table 25: Germany consumer price index (absolute), 2006-10
- Table 26: Germany exchange rate, 2006-10
LIST OF FIGURES
- Figure 1: Germany biotechnology market value: $ million, 2006-10
- Figure 2: Germany biotechnology market segmentation I:% share, by value, 2010
- Figure 3: Germany biotechnology market segmentation II: % share, by value, 2010
- Figure 4: Forces driving competition in the biotechnology market in Germany, 2010
- Figure 5: Drivers of buyer power in the biotechnology market in Germany, 2010
- Figure 6: Drivers of supplier power in the biotechnology market in Germany, 2010
- Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Germany, 2010
- Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Germany, 2010
- Figure 9: Drivers of degree of rivalry in the biotechnology market in Germany, 2010
- Figure 10: Boehringer Ingelheim : revenues & profitability
- Figure 11: Boehringer Ingelheim : assets & liabilities
- Figure 12: MediGene AG: revenues & profitability
- Figure 13: MediGene AG: assets & liabilities
- Figure 14: Merck KGaA: revenues & profitability
- Figure 15: Merck KGaA: assets & liabilities
- Figure 16: Morphosys: revenues & profitability
- Figure 17: Morphosys: assets & liabilities
- Figure 18: Germany biotechnology market value forecast: $ million, 2010-15

Pharmaceutical Market Research

Biotechnology in Germany